Glycogen storage disease type I MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Glycogen storage disease type I}}
{{Glycogen storage disease type I}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{Anmol}}
 
 
==Overview==
==Overview==
Recurrent hypoglycemia causes brain damage in patients with glycogen storage disease type 1. MRI findings in glycogen storage diseases due to brain damage include dilatation of occipital horns and/or hyperintensity of subcortical white matter in the occipital lobes.
Recurrent [[hypoglycemia]] causes [[brain damage]] in patients with glycogen storage disease type 1. [[MRI]] findings in glycogen storage disease type 1 due to [[brain damage]] include [[dilatation]] of [[Occipital lobe|occipital]] horns and/or hyperintensity of [[subcortical]] [[white matter]] in the [[occipital lobes]]. Abdominal [[magnetic resonance imaging]] or [[computed tomography]] with contrast is performed to screen for [[hepatocellular carcinoma]] and repeated every 6 - 12 months or earlier on the basis of [[laboratory]] and clinical findings.


==MRI==
==MRI==
*Recurrent hypoglycemia causes brain damage in patients with glycogen storage disease type 1. MRI findings in glycogen storage diseases due to brain damage include:<ref name="pmid17552001">{{cite journal| author=Ozen H| title=Glycogen storage diseases: new perspectives. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 18 | pages= 2541-53 | pmid=17552001 | doi= | pmc=4146814 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552001  }} </ref>
*Recurrent [[hypoglycemia]] causes [[brain damage]] in patients with glycogen storage disease type 1. MRI findings in glycogen storage diseases type 1 due to [[brain damage]] include:<ref name="pmid17552001">{{cite journal| author=Ozen H| title=Glycogen storage diseases: new perspectives. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 18 | pages= 2541-53 | pmid=17552001 | doi= | pmc=4146814 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552001  }} </ref>
** Dilatation of occipital horns
** [[Dilatation]]  of [[Occipital lobe|occipital]] horns
** Hyperintensity of subcortical white matter in the occipital lobes
** Hyperintensity of [[subcortical]] [[white matter]] in the [[occipital lobes]]
 
*Abdominal [[magnetic resonance imaging]] or [[computed tomography]] with contrast is performed to screen for [[hepatocellular carcinoma]] in patients including:<ref name="KishnaniAustin2014">{{cite journal|last1=Kishnani|first1=Priya S.|last2=Austin|first2=Stephanie L.|last3=Abdenur|first3=Jose E.|last4=Arn|first4=Pamela|last5=Bali|first5=Deeksha S.|last6=Boney|first6=Anne|last7=Chung|first7=Wendy K.|last8=Dagli|first8=Aditi I.|last9=Dale|first9=David|last10=Koeberl|first10=Dwight|last11=Somers|first11=Michael J.|last12=Burns Wechsler|first12=Stephanie|last13=Weinstein|first13=David A.|last14=Wolfsdorf|first14=Joseph I.|last15=Watson|first15=Michael S.|title=Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics|journal=Genetics in Medicine|year=2014|issn=1098-3600|doi=10.1038/gim.2014.128}}</ref>
**Pediatric age group once [[adenoma]] is detected on [[ultrasound]] screening
**Older patients even if there is no [[adenoma]] on [[ultrasound]] screening
*:'''Note:''' These investigations should be repeated every 6 - 12 months or earlier on the basis of [[laboratory]] and clinical findings.


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Gastroenterology]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
 
[[Category:Gastroenterology]]
[[Category:Pediatrics]]
[[Category:Up-To-Date]]
[[Category:Genetic disorders]]
[[Category:Metabolic disorders]]
[[Category:Radiology]]
{{WS}}
{{WS}}
{{WH}}
{{WH}}

Latest revision as of 17:59, 30 November 2017

Glycogen storage disease type I Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glycogen storage disease type I from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glycogen storage disease type I MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glycogen storage disease type I MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glycogen storage disease type I MRI

CDC on Glycogen storage disease type I MRI

Glycogen storage disease type I MRI in the news

Blogs on Glycogen storage disease type I MRI

Directions to Hospitals Treating Glycogen storage disease type I

Risk calculators and risk factors for Glycogen storage disease type I MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

Recurrent hypoglycemia causes brain damage in patients with glycogen storage disease type 1. MRI findings in glycogen storage disease type 1 due to brain damage include dilatation of occipital horns and/or hyperintensity of subcortical white matter in the occipital lobes. Abdominal magnetic resonance imaging or computed tomography with contrast is performed to screen for hepatocellular carcinoma and repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings.

MRI

References

  1. Ozen H (2007). "Glycogen storage diseases: new perspectives". World J Gastroenterol. 13 (18): 2541–53. PMC 4146814. PMID 17552001.
  2. Kishnani, Priya S.; Austin, Stephanie L.; Abdenur, Jose E.; Arn, Pamela; Bali, Deeksha S.; Boney, Anne; Chung, Wendy K.; Dagli, Aditi I.; Dale, David; Koeberl, Dwight; Somers, Michael J.; Burns Wechsler, Stephanie; Weinstein, David A.; Wolfsdorf, Joseph I.; Watson, Michael S. (2014). "Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics". Genetics in Medicine. doi:10.1038/gim.2014.128. ISSN 1098-3600.

Template:WS Template:WH